<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2010</study_start_year><condition>Pulmonary metastases from colorectal cancer</condition><disease>Pulmonary Metastases From Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2620003</full_dataset_link><location>Japan</location><study_start_month>8</study_start_month><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>Pilot Study of chemotherapy with Capecitabine,Oxaliplatin and Bevacizumab for pulmonary metastases from colorectal cancer</name><description>Interventions: Chemotherapy with XELOX(capecitabine+oxaliplatin)+bevacizumab Treatment repeats every 21days for up to 4courses
Primary outcome(s): safety
Study Design: Single arm Non-randomized</description><dates><creation>2010-08-15</creation></dates><accession>2620003</accession><cross_references><Japan Primary Registries Network>JPRN-UMIN000004556</Japan Primary Registries Network></cross_references></HashMap>